Healthcare Market Research Reports and Trends

Increasing privatization in the healthcare sector, poor reimbursement scenario for various medical treatments, large patient population base, and presence of a large number of hospitals/clinics with budget constraints in developing countries are the major factors driving the growth of this market. Growing initiatives undertaken by leading market players (such as GE Healthcare, Philips Healthcare, and Siemens Healthineers) to establish refurbishment facilities in both mature and developing markets are further adding to the growth prospects of Refurbished Medical Equipment market. The  refurbished medical equipment market  is expected to reach  USD 11.91 Billion by 2021 from USD 6.55 Billion in 2016 , at a  CAGR of 12.7%  during the forecast period. Emerging markets including India offer high growth potential for companies engaged in the development and distribution of refurbished medical devices. Growing initiatives by market players, increasing patient pop...

Global prevalence of peripheral artery diseases, increasing geriatric population, and rising prevalence of diabetes. On the other hand, the availability of alternative treatments and product failures and recalls are the major factors that are expected to restrain the growth of this market. The  peripheral vascular devices market  is projected to reach  USD 14.4 billion by 2024 from USD 10.3 billion in 2019 , at a  CAGR of 6.8% . Catheters market is segmented into angiography catheters, guiding catheters, and IVUS/OCT catheters. In 2018, the angiography catheters segment accounted for the largest share of the catheters market. This is mainly due to the high and increasing prevalence of  peripheral vascular diseases , coupled with the increasing awareness about the benefits of the early diagnosis of PVDs. Peripheral Vascular Devices Market, by Product Angioplasty Balloons Old/Normal Balloons Drug-eluting Balloons Cutting and Scoring Balloons Angiop...

Industry is experiencing significant growth due to the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. Global  osteoarthritis therapeutics market  is expected to grow from  USD 6.8 billion in 2019 to reach USD 10.1 billion by 2024 , at a  CAGR of 8.1% . Knee segment to witness the highest growth during the forecast period. Based on anatomy, the market is segmented into knee, hip, hand, and small-joint. The knee osteoarthritis segment accounted for the largest market share in 2018 and is expected to register the highest CAGR during the forecast period. This is attributed to a large number of patients suffering from knee osteoarthritis. Viscosupplementation agents segment to dominate the osteoarthritis therapeutics market in 2018. Based on...

Growth in the fetal and market is mainly driven by the rise in number of preterm and low-weights birth infants, growing number of NICU admissions, and increased awareness of neonatal and fetal care across developing nations. The  fetal and neonatal care equipment market  is projected to grow from an estimated  USD 6.4 billion in 2018 to USD 8.4 billion by 2023 , at a  CAGR of 5.7% . Growth in the in fetal dopplers segment can be attributed to factors such as the growing demand for digital Dopplers over conventional Dopplers and increasing launches of home-use products.  The growing popularity of and demand for fetal Doppler devices is increasing due to the procedural advantages these devices offer, such as ease of use, mobility (handheld and battery-operated products), novel features, and display functionalities. The rising adoption of Doppler imaging (especially in first trimester of pregnancy and for the diagnosis of restricted fetal growth), g...

MarketsandMarkets forecasts the  In Vitro Fertilization market  to grow from  USD 465.2 million in 2016 to 847.8 million by 2022 , at a Compound Annual Growth Rate  (CAGR) of 10.9%  during the forecast period. The major factors that are expected to be driving the IVF market are growth of this market include growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment options. Opportunity: Fertility tourism Asia is one of the most preferred destinations for medical care. One of the major factors driving the medical tourism industry in Asia is the low cost for high-quality healthcare facilities delivered by doctors and surgeons trained and educated in the top institutes in the US and Europe. According to a survey conducted by the International Federation of Fertility Societies in 2013, ther...

Increasing research in the life sciences industry and the growing need to identify antigens associated with autoimmune diseases (through antigen-antibody interaction to understand disease mechanisms and develop relevant drugs targeting these diseases). The  immunoprecipitation market  is expected to grow from  USD 560 million in 2018 to USD 750 million by 2024 , at a  CAGR of 5.0% . Agarose beads accounted for the largest share of the market, by beads type Based on bead type, the immunoprecipitation market is segmented into agarose and magnetic beads. Agarose beads dominated the immunoprecipitation market in 2018. The market for magnetic beads is expected to grow at the highest rate in the forecast period. When IP is performed using superparamagnetic beads, there is no need for centrifugation or time-consuming pre-clearing processes. These advantages of magnetic beads over agarose beads are driving their demand among end users. Download PDF Brochure @ https...

Growing worldwide prevalence of HIV/AIDS, increasing number of blood transfusions and blood donations, benefits offered by point-of-care instruments and kits, and increasing government initiatives are expected to drive the growth of the market worldwide. The  HIV diagnosis market  is projected to reach  USD 3.88 Billion by 2021 from USD 2.35 Billion in 2016 , at a  CAGR of 10.5%  from 2016 to 2021. AIDS is a major public health concern with a prevalence rate that has increased dramatically in the past two decades. This increase in the prevalence of HIV, and the subsequent increase in the number of patients suffering from AIDS, has resulted in an increase in the demand for advanced technologies for HIV diagnostics. According to the World Health Organization (WHO), in 2016, around 36 million people were diagnosed with HIV globally, of which 2.1 million were reported to be cases of new HIV infections. Globally, 1.1 million people died from HIV-related cause...

Increasing incidences of peripheral vascular diseases, liver cancer, strokes, and uterine fibroids coupled with rising preference for minimally invasive procedures; increasing investments, funds, and grants by public-private organizations for research; and technological advancements in the market will fuel the market growth over the forecast period. The  embolotherapy market  is projected to reach  USD 4.9 billion by 2024 from USD 3.3 billion in 2019 , at a  CAGR of 8.1%  from 2019 to 2024. The growth of the embolotherapy market is mainly attributed to factors such as the growth in the target patient population, rising preference for minimally invasive procedures, technological advancements in embolotherapy devices, and favorable reimbursement scenario. The embolic agents segment accounted for the largest share of the embolotherapy market, by product, in 2019 Based on product, the embolotherapy market is segmented into embolic agents (embolic coils, em...

Growing prevalence of dental disorders, rising geriatric population, and the growing dental tourism in emerging countries are the major factors driving the growth of this market. On the other hand, the presence of stringent regulatory and clinical processes is one of the major factors restraining market growth. What the Market Looks Like? Predicted to grow at a CAGR of 7.4 % during the forecast period, the global  dental biomaterials market  is estimated to reach USD 9.6 Billion by the end of 2023. In 2018, Europe held the largest share of this market, and this is primarily attributed to the growing geriatric population, increasing government expenditure on oral healthcare, higher adoption of the dental biomaterials to manufacture implants and other dental products, and growing number of dental hospitals and clinics. Market is segmented into metallic, metal-ceramic, ceramic, polymeric, and natural dental biomaterials the metallic biomaterials segment accounted for the ...